American Cryostem Corporation Is A Clinical Stage Biotechnology Company That Specializes In Autologous Cellular Therapies And Regenerative Medicinefounded In 2008 And Publicly Traded Since 2011The Company Is Dedicated To Standardizing Adipose Tissue Derived Stem Cell Technologies For Therapeutic And Research Purposesit Operates Fda Registered Laboratories In Locations Such As New Jerseyhong Kongand Tokyo The Company Offers A Range Of Servicesincluding Clinical Grade Collectionprocessingand Cryopreservation Of Adipose Tissue And Adult Stem Cellsit Collaborates With Researchers And Clinicians To Develop Applications For Cellular Therapies And Provides Proprietary Technologies To International Partnersamerican Cryostem S Products Include Atcella Can Autologous Stem Cell Therapy In Phase I Clinical Trials For Post Concussion Syndrome And Mild Traumatic Brain Injuryand A Therapy Targeting Post Acute Sequelae Of Sars Cov 2Which Has Received Fda Approval For A Phase I Trialthe Company Serves Patientsphysiciansresearchersand Global Partners In The Field Of Regenerative Medicine
